home.social

#scholcomm — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #scholcomm, aggregated by home.social.

  1. A rare network perspective on lack of access to data:

    "Modeling the impact of research data unavailability on science."
    sciencedirect.com/science/arti

    "We analyzed how the loss of access to research resources propagates through interconnected bodies of scientific work. Our results show that information loss is not merely a local reproducibility issue but a structural phenomenon with system-wide implications…The unavailability of research data imposes a measurable efficiency loss on the scientific system…Preserving or restoring access to datasets associated with structurally central publications may prevent cascading losses that far exceed the local cost of data recovery. This insight provides a quantitative rationale for prioritizing preservation efforts based on network position and propagation risk."

    #Data #OpenData #Preservation #ScholComm

  2. A rare network perspective on lack of access to data:

    "Modeling the impact of research data unavailability on science."
    sciencedirect.com/science/arti

    "We analyzed how the loss of access to research resources propagates through interconnected bodies of scientific work. Our results show that information loss is not merely a local reproducibility issue but a structural phenomenon with system-wide implications…The unavailability of research data imposes a measurable efficiency loss on the scientific system…Preserving or restoring access to datasets associated with structurally central publications may prevent cascading losses that far exceed the local cost of data recovery. This insight provides a quantitative rationale for prioritizing preservation efforts based on network position and propagation risk."

    #Data #OpenData #Preservation #ScholComm

  3. A rare network perspective on lack of access to data:

    "Modeling the impact of research data unavailability on science."
    sciencedirect.com/science/arti

    "We analyzed how the loss of access to research resources propagates through interconnected bodies of scientific work. Our results show that information loss is not merely a local reproducibility issue but a structural phenomenon with system-wide implications…The unavailability of research data imposes a measurable efficiency loss on the scientific system…Preserving or restoring access to datasets associated with structurally central publications may prevent cascading losses that far exceed the local cost of data recovery. This insight provides a quantitative rationale for prioritizing preservation efforts based on network position and propagation risk."

    #Data #OpenData #Preservation #ScholComm

  4. A rare network perspective on lack of access to data:

    "Modeling the impact of research data unavailability on science."
    sciencedirect.com/science/arti

    "We analyzed how the loss of access to research resources propagates through interconnected bodies of scientific work. Our results show that information loss is not merely a local reproducibility issue but a structural phenomenon with system-wide implications…The unavailability of research data imposes a measurable efficiency loss on the scientific system…Preserving or restoring access to datasets associated with structurally central publications may prevent cascading losses that far exceed the local cost of data recovery. This insight provides a quantitative rationale for prioritizing preservation efforts based on network position and propagation risk."

    #Data #OpenData #Preservation #ScholComm

  5. A rare network perspective on lack of access to data:

    "Modeling the impact of research data unavailability on science."
    sciencedirect.com/science/arti

    "We analyzed how the loss of access to research resources propagates through interconnected bodies of scientific work. Our results show that information loss is not merely a local reproducibility issue but a structural phenomenon with system-wide implications…The unavailability of research data imposes a measurable efficiency loss on the scientific system…Preserving or restoring access to datasets associated with structurally central publications may prevent cascading losses that far exceed the local cost of data recovery. This insight provides a quantitative rationale for prioritizing preservation efforts based on network position and propagation risk."

    #Data #OpenData #Preservation #ScholComm

  6. Agreed: Sharing scholarship on #SocialMedia is another kind of scholarly communication, usefully supplementing traditional channels. And there are better and worse ways to do it.

    "From publication to Dissemination: Using #SocialMedia to Extend Scholarly Reach and Impact."
    academic.oup.com/academicmedic

    "First, increasing the visibility of scholarship is a legitimate scholarly aim, not merely a marketing exercise, because greater visibility can help scholarship reach relevant audiences, stimulate engagement, and generate evidence of dissemination that complements traditional markers of impact. Second, concerns about self-promotion are understandable but should be reframed. Sharing one’s work is more appropriately viewed as an act of scholarly dissemination and knowledge translation than as self-congratulatory or performative."

    #ScholComm

  7. The US Government Accountability Office (#GAO) just reviewed the #OpenAccess policies at nine federal agencies.
    gao.gov/products/gao-26-107738

    A few highlights:

    * Among other things, GAO looked for compliance with the #NelsonMemo. This is further evidence that the #Trump admin supports the memo.

    * It encourages #NSF and #USDA to go further to ensure #reuse rights. (That would be good.) But it assumes that the other agencies are already doing enough to ensure reuse rights. (I can't agree with this.)

    * It praises #NIH for taking steps to reduce money spent on grantee #APCs, and encourages other agencies to follow the NIH lead on this.

    * In a few places it leaves the false impression (1) that all OA journals charge APCs and (2) that all publishers are responding the federal policies by charging APCs to publish fed-funded research.

    #PublicAccess #ScholComm #USPol #USPolitics

  8. The US Government Accountability Office (#GAO) just reviewed the #OpenAccess policies at nine federal agencies.
    gao.gov/products/gao-26-107738

    A few highlights:

    * Among other things, GAO looked for compliance with the #NelsonMemo. This is further evidence that the #Trump admin supports the memo.

    * It encourages #NSF and #USDA to go further to ensure #reuse rights. (That would be good.) But it assumes that the other agencies are already doing enough to ensure reuse rights. (I can't agree with this.)

    * It praises #NIH for taking steps to reduce money spent on grantee #APCs, and encourages other agencies to follow the NIH lead on this.

    * In a few places it leaves the false impression (1) that all OA journals charge APCs and (2) that all publishers are responding the federal policies by charging APCs to publish fed-funded research.

    #PublicAccess #ScholComm #USPol #USPolitics

  9. The US Government Accountability Office (#GAO) just reviewed the #OpenAccess policies at nine federal agencies.
    gao.gov/products/gao-26-107738

    A few highlights:

    * Among other things, GAO looked for compliance with the #NelsonMemo. This is further evidence that the #Trump admin supports the memo.

    * It encourages #NSF and #USDA to go further to ensure #reuse rights. (That would be good.) But it assumes that the other agencies are already doing enough to ensure reuse rights. (I can't agree with this.)

    * It praises #NIH for taking steps to reduce money spent on grantee #APCs, and encourages other agencies to follow the NIH lead on this.

    * In a few places it leaves the false impression (1) that all OA journals charge APCs and (2) that all publishers are responding the federal policies by charging APCs to publish fed-funded research.

    #PublicAccess #ScholComm #USPol #USPolitics

  10. The US Government Accountability Office (#GAO) just reviewed the #OpenAccess policies at nine federal agencies.
    gao.gov/products/gao-26-107738

    A few highlights:

    * Among other things, GAO looked for compliance with the #NelsonMemo. This is further evidence that the #Trump admin supports the memo.

    * It encourages #NSF and #USDA to go further to ensure #reuse rights. (That would be good.) But it assumes that the other agencies are already doing enough to ensure reuse rights. (I can't agree with this.)

    * It praises #NIH for taking steps to reduce money spent on grantee #APCs, and encourages other agencies to follow the NIH lead on this.

    * In a few places it leaves the false impression (1) that all OA journals charge APCs and (2) that all publishers are responding the federal policies by charging APCs to publish fed-funded research.

    #PublicAccess #ScholComm #USPol #USPolitics

  11. The US Government Accountability Office (#GAO) just reviewed the #OpenAccess policies at nine federal agencies.
    gao.gov/products/gao-26-107738

    A few highlights:

    * Among other things, GAO looked for compliance with the #NelsonMemo. This is further evidence that the #Trump admin supports the memo.

    * It encourages #NSF and #USDA to go further to ensure #reuse rights. (That would be good.) But it assumes that the other agencies are already doing enough to ensure reuse rights. (I can't agree with this.)

    * It praises #NIH for taking steps to reduce money spent on grantee #APCs, and encourages other agencies to follow the NIH lead on this.

    * In a few places it leaves the false impression (1) that all OA journals charge APCs and (2) that all publishers are responding the federal policies by charging APCs to publish fed-funded research.

    #PublicAccess #ScholComm #USPol #USPolitics

  12. 🤝 Is upgrading to OJS 3.5 important for your journal stability, security, and workflow? Join us in an upcoming event to learn more:

    📅 June 3 2026, 8 PDT: PKP and @crossref.bsky.social present – Introducing OJS 3.5: Key features and user enhancements

    Journal managers and editors using OJS, this one's for you!

    Can't make it? Register anyway and get the recording:

    eventbrite.ca/e/pkp-crossref-i

    #OpenJournalSystems #ScholarlyPublishing #ScholComm #OpenAccess #DiamondOpenAccess

  13. 🤝 Is upgrading to OJS 3.5 important for your journal stability, security, and workflow? Join us in an upcoming event to learn more:

    📅 June 3 2026, 8 PDT: PKP and @crossref.bsky.social present – Introducing OJS 3.5: Key features and user enhancements

    Journal managers and editors using OJS, this one's for you!

    Can't make it? Register anyway and get the recording:

    eventbrite.ca/e/pkp-crossref-i

    #OpenJournalSystems #ScholarlyPublishing #ScholComm #OpenAccess #DiamondOpenAccess

  14. 🤝 Is upgrading to OJS 3.5 important for your journal stability, security, and workflow? Join us in an upcoming event to learn more:

    📅 June 3 2026, 8 PDT: PKP and @crossref.bsky.social present – Introducing OJS 3.5: Key features and user enhancements

    Journal managers and editors using OJS, this one's for you!

    Can't make it? Register anyway and get the recording:

    eventbrite.ca/e/pkp-crossref-i

    #OpenJournalSystems #ScholarlyPublishing #ScholComm #OpenAccess #DiamondOpenAccess

  15. 🤝 Is upgrading to OJS 3.5 important for your journal stability, security, and workflow? Join us in an upcoming event to learn more:

    📅 June 3 2026, 8 PDT: PKP and @crossref.bsky.social present – Introducing OJS 3.5: Key features and user enhancements

    Journal managers and editors using OJS, this one's for you!

    Can't make it? Register anyway and get the recording:

    eventbrite.ca/e/pkp-crossref-i

    #OpenJournalSystems #ScholarlyPublishing #ScholComm #OpenAccess #DiamondOpenAccess

  16. 🤝 Is upgrading to OJS 3.5 important for your journal stability, security, and workflow? Join us in an upcoming event to learn more:

    📅 June 3 2026, 8 PDT: PKP and @crossref.bsky.social present – Introducing OJS 3.5: Key features and user enhancements

    Journal managers and editors using OJS, this one's for you!

    Can't make it? Register anyway and get the recording:

    eventbrite.ca/e/pkp-crossref-i

    #OpenJournalSystems #ScholarlyPublishing #ScholComm #OpenAccess #DiamondOpenAccess

  17. #ScholComm and #metascience folks beware that there's now a second #FAIR acronym. The first was Findability, Accessibility, Interoperability, and Reusability. The new one is Fairness, Accountability, Integrity, and Responsibility. It's an "ethically-guided hybrid #peerreview system" mixing #AI and human expertise.
    degruyterbrill.com/document/do

  18. #ScholComm and #metascience folks beware that there's now a second #FAIR acronym. The first was Findability, Accessibility, Interoperability, and Reusability. The new one is Fairness, Accountability, Integrity, and Responsibility. It's an "ethically-guided hybrid #peerreview system" mixing #AI and human expertise.
    degruyterbrill.com/document/do

  19. #ScholComm and #metascience folks beware that there's now a second #FAIR acronym. The first was Findability, Accessibility, Interoperability, and Reusability. The new one is Fairness, Accountability, Integrity, and Responsibility. It's an "ethically-guided hybrid #peerreview system" mixing #AI and human expertise.
    degruyterbrill.com/document/do

  20. #ScholComm and #metascience folks beware that there's now a second #FAIR acronym. The first was Findability, Accessibility, Interoperability, and Reusability. The new one is Fairness, Accountability, Integrity, and Responsibility. It's an "ethically-guided hybrid #peerreview system" mixing #AI and human expertise.
    degruyterbrill.com/document/do

  21. #ScholComm and #metascience folks beware that there's now a second #FAIR acronym. The first was Findability, Accessibility, Interoperability, and Reusability. The new one is Fairness, Accountability, Integrity, and Responsibility. It's an "ethically-guided hybrid #peerreview system" mixing #AI and human expertise.
    degruyterbrill.com/document/do

  22. If you sit in the editorial board of a scholarly / scientific journal, or are adjacent or interested on this kind of stuff, you should probably read this:

    "The scientific journal, beyond experts: the communication strategies of The New England Journal of Medicine and The Lancet"

    doi.org/10.1590/S0104-59702026

    #ScholComm

  23. 🚀 Keynote preview!
    Dr. Kenneth Ruud on “Open science in a closing world” 🌍
    How do we keep openness, trust & integrity when knowledge becomes geopolitical?
    🔍 Abstract: doi.org/10.7557/5.8356
    #Munin2025 #OpenScience #ResearchIntegrity #ScholComm #UiT

  24. #OpenPharma just published a vision statement calling on #pharma companies to make their research #OpenAccess.
    bmjopen.bmj.com/content/16/5/e

    The vision statement calls for OpenAccess to texts, #OpenData (under #FAIR principles), open #PIDS (#ORCID and #ROR), plain language summaries, and patient involvement.

    It understands that the goal is a stretch. and distinguishes easier short-term goals from harder long-term goals, while arguing for both.

    OpenPharma is funded by voluntary contributions from pharma companies, and considers itself a collaboration of "a number of important stakeholder groups: the pharmaceutical industry, publishers, patients, academics, regulators, editors, non-pharmaceutical funders and societies."
    openpharma.blog/wp-content/upl

    Also see the OpenPharma home page.
    openpharma.blog/

    #Medicine #OpenScience #ScholComm

  25. #OpenPharma just published a vision statement calling on #pharma companies to make their research #OpenAccess.
    bmjopen.bmj.com/content/16/5/e

    The vision statement calls for OpenAccess to texts, #OpenData (under #FAIR principles), open #PIDS (#ORCID and #ROR), plain language summaries, and patient involvement.

    It understands that the goal is a stretch. and distinguishes easier short-term goals from harder long-term goals, while arguing for both.

    OpenPharma is funded by voluntary contributions from pharma companies, and considers itself a collaboration of "a number of important stakeholder groups: the pharmaceutical industry, publishers, patients, academics, regulators, editors, non-pharmaceutical funders and societies."
    openpharma.blog/wp-content/upl

    Also see the OpenPharma home page.
    openpharma.blog/

    #Medicine #OpenScience #ScholComm

  26. #OpenPharma just published a vision statement calling on #pharma companies to make their research #OpenAccess.
    bmjopen.bmj.com/content/16/5/e

    The vision statement calls for OpenAccess to texts, #OpenData (under #FAIR principles), open #PIDS (#ORCID and #ROR), plain language summaries, and patient involvement.

    It understands that the goal is a stretch. and distinguishes easier short-term goals from harder long-term goals, while arguing for both.

    OpenPharma is funded by voluntary contributions from pharma companies, and considers itself a collaboration of "a number of important stakeholder groups: the pharmaceutical industry, publishers, patients, academics, regulators, editors, non-pharmaceutical funders and societies."
    openpharma.blog/wp-content/upl

    Also see the OpenPharma home page.
    openpharma.blog/

    #Medicine #OpenScience #ScholComm

  27. #OpenPharma just published a vision statement calling on #pharma companies to make their research #OpenAccess.
    bmjopen.bmj.com/content/16/5/e

    The vision statement calls for OpenAccess to texts, #OpenData (under #FAIR principles), open #PIDS (#ORCID and #ROR), plain language summaries, and patient involvement.

    It understands that the goal is a stretch. and distinguishes easier short-term goals from harder long-term goals, while arguing for both.

    OpenPharma is funded by voluntary contributions from pharma companies, and considers itself a collaboration of "a number of important stakeholder groups: the pharmaceutical industry, publishers, patients, academics, regulators, editors, non-pharmaceutical funders and societies."
    openpharma.blog/wp-content/upl

    Also see the OpenPharma home page.
    openpharma.blog/

    #Medicine #OpenScience #ScholComm

  28. #OpenPharma just published a vision statement calling on #pharma companies to make their research #OpenAccess.
    bmjopen.bmj.com/content/16/5/e

    The vision statement calls for OpenAccess to texts, #OpenData (under #FAIR principles), open #PIDS (#ORCID and #ROR), plain language summaries, and patient involvement.

    It understands that the goal is a stretch. and distinguishes easier short-term goals from harder long-term goals, while arguing for both.

    OpenPharma is funded by voluntary contributions from pharma companies, and considers itself a collaboration of "a number of important stakeholder groups: the pharmaceutical industry, publishers, patients, academics, regulators, editors, non-pharmaceutical funders and societies."
    openpharma.blog/wp-content/upl

    Also see the OpenPharma home page.
    openpharma.blog/

    #Medicine #OpenScience #ScholComm

  29. Now available: the recording and slides from our community webinar on configuring Dataverse to register DataCite DOIs. Explore DOI registration in Dataverse, tips for improving discoverability with metadata, and other practical guidance from the Dataverse Project & DataCite: youtube.com/watch?v=YuNgI7crG5M

    #Dataverse #DataCite #DOI #PersistentIdentifiers #PID #Metadata #ResearchData #OpenScience #ScholComm #DataManagement

  30. Now available: the recording and slides from our community webinar on configuring Dataverse to register DataCite DOIs. Explore DOI registration in Dataverse, tips for improving discoverability with metadata, and other practical guidance from the Dataverse Project & DataCite: youtube.com/watch?v=YuNgI7crG5M

    #Dataverse #DataCite #DOI #PersistentIdentifiers #PID #Metadata #ResearchData #OpenScience #ScholComm #DataManagement

  31. #COAR (@coar_repositories) is exactly right about what's wrong with the #ACS and #IEEE demands that their authors pay them a fee for the right to deposit their accepted author manuscripts (#AAMs) in #OpenAccess #repositories.
    coar-repositories.org/news-upd

    <blockquote>
    * The charges applied are completely arbitrary and not based on any real service provision (for example, IEEE applies a fee to authors who want to apply a CC-BY licence to their AAM; and ACM applies a fee for removing the embargo period). They are just another funding stream for publishers that are already making huge profits.
    * Deposit fees disadvantage authors who do not have funding to pay
    * These fees amount to #DoubleDipping since the final published version of the AAM is made available behind a paywall with no discount
    * This practice prevents universities and research organisations from creating an accessible record of their scholarly output.
    </blockquote>

    And COAR is exactly right about the solution: author #RightsRetention. When authors retain key rights, they don't need publisher permission to deposit their works in OA repositories -- or to use and reuse them in other important ways as well.

    PS: See my similar argument on a related ACS move last year.
    fediscience.org/@petersuber/11

    #Publishers #Copyright #ScholComm

  32. #CancerResearchUK will stop paying #APCs for funded researchers.
    news.cancerresearchuk.org/2026

    PS. So far, so good. There are strong reasons to move away from APCs. For a summary, see Recommendation 3 of the Budapest Open Access Initiative 20th anniversary statement in 2022. (Disclosure: I was the lead author.)
    budapestopenaccessinitiative.o

    Unfortunately the Cancer Research UK announcement is marred by several false assertions and assumptions about #OpenAccess.

    * Its narrow decision is to stop funding APCs, but its headline is that it will stop funding OA publishing as such. It leaves the distinct false impression that all OA journals charge APCs.

    * Deep in the text it says that OA "hasn't worked. At least not in its current form." That looks like a recognition that not all OA depends on APCs. But it isn't explicit and didn't prevent careless language elsewhere in the statement.

    * It never acknowledges that no-APC OA (#DiamondOA) journals exist, let alone that they constitute the majority of OA journals.

    * It does acknowledge the existence of no-APC OA through repositories, or #GreenOA. But it falsely suggests that green OA must be embargoed. Just to give one notable set of counter-examples, all the federal OA policies in the US require unembargoed green OA.

    #ScholComm

  33. "Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers" link.springer.com/article/10.1

    Critique by @lonnibesancon et al. of a paper by Seneff et al., “Innate immunosuppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs”, in Elsevier journal Food and Chemical Toxicology (FCT): the journal refused to publish a letter to the editor.

    #PublicationEthics #ScholComm #COVID19 #Disinformation #AntiVax #SARSCoV2 #mRNAvaccine

  34. Update. I'm very glad to see the #DOAJ endorse the #PKP "Publication Facts" label.
    blog.doaj.org/2026/04/22/intro

    I hope this nudges more publishers to use the labels. In any case, it should lead more readers to expect publishers to use them.

    #ScholComm
    @DOAJ
    @PublicKnowledgeProject

  35. Update. I'm very glad to see the #DOAJ endorse the #PKP "Publication Facts" label.
    blog.doaj.org/2026/04/22/intro

    I hope this nudges more publishers to use the labels. In any case, it should lead more readers to expect publishers to use them.

    #ScholComm
    @DOAJ
    @PublicKnowledgeProject

  36. Update. I'm very glad to see the #DOAJ endorse the #PKP "Publication Facts" label.
    blog.doaj.org/2026/04/22/intro

    I hope this nudges more publishers to use the labels. In any case, it should lead more readers to expect publishers to use them.

    #ScholComm
    @DOAJ
    @PublicKnowledgeProject

  37. Kudos to the Howard Hughes Medical Institute (#HHMI) for strengthening its 2022 #OpenAccess policy to require the immediate sharing of new research through #preprints under #CCBY licenses.
    hhmicdn.blob.core.windows.net/

    This kind of policy is often called #Plan_U, though HHMI doesn't use that term. The policy takes effect January 1, 2026.

    For background, here are the items tagged with "oa.plan_u" in the Open Access Tracking Project (#OATP, @oatp).
    tagteam.harvard.edu/hubs/oatp/

    #Medicine #ScholComm

  38. Very interesting results of #AAAS survey on researcher positions on #OpenLicenses. Note that I'm over 70.
    aaas.org/news/interests-concer

    <blockquote>
    * 42% of respondents — when asked what they prefer to do with #CCBY licensed content where they use it themselves— mentioned actions that don’t necessarily require this license, like reading work, or sharing it in the classroom.
    * 29% of respondents say there should be no limitations on the #reuse of peer-reviewed research at all, with those older than 70 years of age feeling most strongly.
    * 28% of respondents were concerned about reuses of work with a CC-BY license, largely related to possible misrepresentations of their work. Some cited concerns about misuse of their data for political gain.
    * In general, younger researchers were slightly more concerned than their older counterparts about potential downstream misuses of their work.
    * With respect to commercial reuses of published work, about 36% indicated that there are cases that excite them, while roughly 63% indicated that there are cases that worry them. The latter group’s concerns relate to the possibility of misrepresentation by media and other groups or individuals; use by unsanctioned entities seeking to make a profit; and training of #AI models without proper attribution.
    </blockquote>

    #CreativeCommons #Libre #Licenses #ScholComm

  39. Update. The passage in the #Trump budget criticizing expensive #subscriptions and #APCs (previous post, this thread) triggered a debate in the House of Representatives.

    "US lawmakers intensify scrutiny of scientific-publishing practices."
    nature.com/articles/d41586-026

    "From ‘paper mills’ that sell authorships on fake or low-quality research papers to the costs associated with open-access publishing, US lawmakers are paying increasing attention to widely debated issues in scientific publishing. In a rare show of unity, members of the US House of Representatives from both sides of the political aisle agreed at a hearing that these issues deserve more attention from government — but there was less unity on what the solutions should be."

    #OpenAccess #Publishing #ScholComm

  40. Update. Here's the key passage from the new #Trump budget proposing a "Government-Wide Prohibition on Publishing and Subscription Fees." See p. 17.
    whitehouse.gov/wp-content/uplo

    "The Budget ends the diversion of research dollars to high priced publishers across the Government. The Budget prohibits the use of Federal funds for expensive subscriptions to academic journals and prohibitively high publishing costs unless required by Federal statute or approved in advance by a Federal agency. Research funded by taxpayers should be publicly accessible; yet many publications charge the Government to both publish and to access the same research study. There are numerous low-cost outlets to make federally-funded research publicly available."

    h/t Jim O'Donnell

    #APCs #DoubleDipping #OpenAccess #Publishing #ScholComm #Subscriptions

  41. Here's another article that made it through peer review (at #Elsevier) with the false claim that all #OpenAccess journals charge #APCs. www.journalofsurgicalresearch.com/article/S002... #ScholComm

  42. Here's another article that made it through peer review (at #WoltersKluwer) falsely asserting that all #OpenAccess journals charge #APCs. dx.doi.org/10.1097/SAP.... (#paywalled) The article never mentions no-fee OA journals ( #DiamondOA ) or no-fee OA repositories ( #GreenOA ). #ScholComm